StreetAlpha.app
Home › Stocks › APYX

Apyx Medical Corp (APYX)

$2.40
▲ +0.42%
LAST CLOSE · NOV 20

Apyx Medical makes surgical devices used in cosmetic surgery and hospital operations. It last closed at $2.40 on Nov 20, up 0.42% on the day. The next earnings report for APYX is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, APYX reported EPS of -$0.04 on revenue of $14.0M, with revenue up 9.0% from a year ago. Over its last 8 reports the stock moved an average of 10.2% the session after earnings.

AI Auto Pilots
Is APYX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold APYX.

Key Stats

Last 12 months
Results
Revenue
$59.6M
+24.4% vs a year ago
Net income
−$8.4M
−14.2% margin
EPS (diluted)
−$0.19
Free cash flow
−$8.9M
−14.9% margin
Valuation
Market cap
$101.1M
42.1M shares
P/E
–
No P/E while losing money
Price to sales
1.7
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$25.8M
At Sep 30
Debt
$37.5M
At Sep 30
Shareholder equity
$9.6M
Shares outstanding
42.1M
At Nov 4
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $48.5M$48.5MFY2021FY2022: $44.5M$44.5MFY2022FY2023: $52.3M$52.3MFY2023FY2024: $48.1M$48.1MFY2024FY2025: $52.8M$52.8MFY2025

From APYX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Jan 11
Estimated date · Time not announced
Reported EPS
-$0.04
Quarter ended Sep 2026
Year ago EPS
-$0.05
Same quarter last year
Revenue
$14.0M
+9.0% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.12Dec '24Mar 2025: -$0.10Mar '25Jun 2025: -$0.09Jun '25Sep 2025: -$0.05Sep '25Dec 2025: -$0.03Dec '25Mar 2026: -$0.05Mar '26Jun 2026: -$0.07Jun '26Sep 2026: -$0.04Sep '26Latest -$0.04
Revenue by quarter
Dec 2024: $14.2MDec '24Mar 2025: $9.4MMar '25Jun 2025: $11.4MJun '25Sep 2025: $12.9MSep '25Dec 2025: $19.2MDec '25Mar 2026: $12.5MMar '26Jun 2026: $13.9MJun '26Sep 2026: $14.0MSep '26Latest $14.0M
How APYX moved after its last 8 reports
Average move the session after a report ±10.2%
Nov 5, 2026Time not announced+18.1%
Aug 6, 2026After the close−2.6%
May 7, 2026Time not announced+21.9%
Mar 10, 2026Time not announced+0.6%
Jan 12, 2026Time not announced+14.9%
Nov 6, 2025Time not announced+6.7%
Aug 7, 2025After the close+11.2%
May 8, 2025Time not announced−5.6%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on APYXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on APYX
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on APYX

Technical Analysis

APYX · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold

The stock is 12% below its 20 day and 11% below its 50 day average. It is 46% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 38), near oversold. The nearest support is the Pivot S1 at $2.35, and the nearest resistance the Pivot R1 at $2.46.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 8.6%/day
Key levels
$5.0852 week high+111.7%
$3.50200 day average+45.8%
$3.15100 day average+31.3%
$2.6820 day average+11.7%
$2.6750 day average+11.3%
$2.63Swing high (Oct 6)+9.6%
$2.46Pivot R1+2.5%
$2.40Pivot+0.0%
$2.40Last close
$2.35Pivot S1−2.1%
$2.34Swing low (Oct 8)−2.5%
$2.2552 week low−6.3%
Indicators
RSI (14)37.88Weak, oversold below 30Neutral
MACD-0.04Below its signal lineBearish
Stochastic6.8Near the bottom of its rangeOversold
ADX (14)24.0Weak trend
Williams %R-94.7Oversold below −80, overbought above −20Oversold
CCI (20)-104.1Oversold below −100, overbought above 100Oversold
Rate of change−18.1%Change over 10 sessionsBearish
ATR (14)$0.21Typical daily range, 8.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for APYX

What happened before

See how APYX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow APYX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How APYX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for APYXHow many large options trades hit APYX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

APYX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼23 buying vs 42 selling
  • ▼Held by funds -8.7 pts
  • ▼Funds holding -1
  • ▼Superinvestors: 0 added, 4 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding6970−1.4%
In funds' top 1001−100.0%
Held by funds49.9%58.6%−8.7 pts
New / increased11 / 1212 / 24−36.1%
Reduced / sold out30 / 1222 / 10+31.3%
Put/call ratio0.000.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See APYX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether APYX is in one of them and how their past APYX trades turned out.

APYX in the AI portfolios
Loading…

APYX News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered APYX in an article yet. Here's the latest on the wider market.

APYX in the news

About Apyx Medical

Apyx Medical is a surgical device company based in Clearwater, Florida. It makes Renuvion and the AYON Body Contouring System for cosmetic surgeons, and J-Plasma for hospital surgery, using controlled heat delivered to tissue. The company also supplies its technology to other device makers under OEM agreements. Its products are sold through a direct sales force and international distributors.

Headquarters
Clearwater, FL